İbrahim Yalçın

7PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCancer geneticsObstetrics and gynaecologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 05, 2025
Prognostic value of chemotherapy response score in advanced ovarian cancer: a single-center retrospective analysis.

Hamdullah Sözen, Yagmur Minareci, Atahan Toyran

|Oct 14, 2025
Challenges in Fertility Preservation for p53abn Grade 2 Endometrioid Endometrial Cancer: A Case Report and Literature Review.

Ibrahim Yalcin, Hakan Kula, Alper Baysal

|Jan 04, 2021
High-grade endometrial stromal sarcoma versus undifferentiated uterine sarcoma: a Turkish uterine sarcoma group study-001.

Ali Ayhan, Mehmet Tunc, Nurettin Boran

|Jan 04, 2021
Morcellation in gynecology: short review and suggestions from Turkish Society of Minimally Invasive Gynecologic Oncology

Salih Taşkın, Bulut Varlı, İbrahim Yalçın

|Dec 04, 2020
Management of gynecological cancers in the COVID-19 era: a survey from Turkey

Duygu Altın, İbrahim Yalçın, Ghanim Khatib

|Nov 17, 2017
Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.

Ibrahim Yalcin, Mehmet Mutlu Meydanli, Ahmet Taner Turan

Pageof 2